Log In
Print
BCIQ
Print
Print this Print this
 

RD-100i OSNA system

  Manage Alerts
Collapse Summary General Information
Company Sysmex Corp.
DescriptionIntraoperative automated test that uses 1-step mRNA amplification to detect cytokeratin 19 (CK19; KRT19) in soluble biopsy samples of sentinel lymph node tissue
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDetect sentinel lymph node metastases in people with early invasive breast cancer who have a sentinel lymph node biopsy and in whom axillary lymph node dissection will be considered
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today